MorphoSys is a publicly traded biotechnology company focused on the generation of fully human antibodies as a means to discover and develop innovative antibody-based drugs against life-threatening diseases. The Company owns the unique HuCAL (Human Combinatorial Antibody Library) technology, comprising several billion different, fully human antibodies. With currently some 70 distinct drugs in research and development, MorphoSys has one of the broadest antibody pipelines in the biotechnology industry. Via its business unit AbD Serotec, MorphoSys is expanding the reach of its technologies in the diagnostics and research markets.

Acquired Companies: Sloning BioTechnology GmbH